Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$301M |
| 2 |
JPMorgan Chase
JPM
|
+$284M |
| 3 |
Wells Fargo
WFC
|
+$279M |
| 4 |
Philip Morris
PM
|
+$224M |
| 5 |
Cisco
CSCO
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$630M |
| 2 |
Chevron
CVX
|
+$444M |
| 3 |
Coca-Cola
KO
|
+$414M |
| 4 |
Merck
MRK
|
+$388M |
| 5 |
PepsiCo
PEP
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Healthcare | 20.79% |
| 3 | Consumer Staples | 19.28% |
| 4 | Communication Services | 6.05% |
| 5 | Industrials | 5.76% |
Similar funds
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2014 Portfolio in Review
As of Q1 2014, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $38.3B, down 7% from $41.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $3.32B in Q1 2014, closing 180 positions and reducing 316 holdings. Its most notable exit was BROOKFIELD OFFICE PROPERTIES. INC, an estimated $37.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Xilinx Inc worth $58.7M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2014 buy was Xilinx Inc: 1,081,003 shares worth $58.7M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Apple in Q1 2014, an estimated $301M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2014 reduction was Pfizer, cutting an estimated $630M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited BROOKFIELD OFFICE PROPERTIES. INC in Q1 2014, selling an estimated $37.7M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $38.3B portfolio in Q1 2014.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 180 in Q1 2014.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7% quarter-over-quarter to $38.3B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2014, filed 14 May 2014.